Cystic fibrosis year in review 2024

被引：0

作者：

Alameeri, Amel ^{[1
]}

Yavuz, Burcu Capraz ^{[2
]}

Lucca, Francesca ^{[3
]}

Bambir, Ivan ^{[4
]}

Famulska, Paulina ^{[5
]}

Cohen, Renata W. F. ^{[6
]}

机构：

[1] ST Shaikh Tahnoon Med City Hosp, Dept Adult Pulm Med, Al Ain, Abudhabi, U Arab Emirates

[2] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Pulmonol, Ankara, Turkiye

[3] AOUI Verona, Cyst Fibrosis Ctr, Cardiothoracovasc Dept, Verona, Italy

[4] Univ Hosp Ctr Zagreb, Cyst Fibrosis Ctr Peadiatr & Adult Zagreb, Zagreb, Croatia

[5] Polanki Childrens Hosp, Dept Pediat & Cyst Fibrosis, Gdansk, Poland

[6] Inst Fernandes Figueira FIOCRUZ, Pediat Cyst Fibrosis Ctr, Dept Pediat Pulmonol, Rio De Janeiro, RJ, Brazil

来源：

JOURNAL OF CYSTIC FIBROSIS | 2025年 / 24卷 / 02期

关键词：

Cystic fibrosis; CFTR-RELATED DISORDERS; ECFS STANDARDS; MODULATOR USE; ELEXACAFTOR/TEZACAFTOR/IVACAFTOR; CHILDREN; ADULTS; IMPACT; CARE;

D O I：

10.1016/j.jcf.2025.02.012

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The year 2024 marks a pivotal moment in the field of cystic fibrosis (CF) treatment, characterised by significant advancements in clinical care and an expanding body of literature on CF transmembrane conductance regulator (CFTR) modulators. These CFTR therapies have transformed the landscape of CF management, offered systemic benefits, and established new guidelines for assessing clinical manifestations and therapies. Additionally, progress has been made in newborn screening (NBS), diagnosis, and understanding outcomes for individuals with CF-related metabolic syndrome or inconclusive diagnostic results. However, amidst these clinical milestones, disparities in global access to CFTR modulators (CFTRm) persist, threatening to exacerbate existing inequities in CF care. This review provides a focused overview of the most impactful articles from 2024, highlighting both the clinical advancements and the pressing global accessibility challenges that define this transformative era in CF research and treatment.

引用

页码：218 / 223

页数：6

共 50 条

[1] Cystic fibrosis: year in review
Boyle, Michael P.
CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (06) : 583 - 583
[2] Cystic fibrosis year in review 2022
Kim, Jeeyeon
Lyman, Benjamin
Savant, Adrienne P. P.
PEDIATRIC PULMONOLOGY, 2023, 58 (11) : 3013 - 3022
[3] 2014 year in review: Cystic fibrosis
Savant, Adrienne P.
McColley, Susanna A.
PEDIATRIC PULMONOLOGY, 2015, 50 (11) : 1147 - 1156
[4] Cystic fibrosis year in review 2023
Swetland, David V.
Savant, Adrienne P.
PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3106 - 3116
[5] Cystic fibrosis year in review 2021
Savant, Adrienne P.
PEDIATRIC PULMONOLOGY, 2022, 57 (07) : 1590 - 1599
[6] Cystic fibrosis year in review 2016
Savant, Adrienne P.
McColley, Susanna A.
PEDIATRIC PULMONOLOGY, 2017, 52 (08) : 1092 - 1102
[7] Cystic fibrosis year in review 2017
Savant, Adrienne P.
McColley, Susanna A.
PEDIATRIC PULMONOLOGY, 2018, 53 (09) : 1307 - 1317
[8] Cystic fibrosis 2019: Year in review
Doull, Iolo
PAEDIATRIC RESPIRATORY REVIEWS, 2020, 35 : 95 - 98
[9] Cystic Fibrosis 2017-The Year in Review
Rubin, Bruce K.
RESPIRATORY CARE, 2018, 63 (02) : 238 - 241
[10] Surgery in cystic fibrosis - a 20-year review
Westwood, ATR
Ireland, JD
Bowie, MD
SOUTH AFRICAN JOURNAL OF SURGERY, 1997, 35 (04) : 181 - 184

← 1 2 3 4 5 →